NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/30/2025
Back to search
Official data from USPTO
BACHEM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BACHEM
ST13
US500000079281569Class
1, 5, 40, 42
Filing
79281569
Registration
6748998
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
12/01/2025
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
12/27/2019
Registration date
06/07/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/07/2022
Last transaction
12/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
CIANCI,RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bachem Holding AG
Representatives
Sarah M. Robertson Dorsey & Whitney LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemical preparations for scientific use; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific use; chemical preparations for scientific useother than for medical or veterinary use; chemical reagentsother than for medical or veterinary use; chemicals for industry; chemical reagents for scientific use; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; oligopeptides for industrial use; proteins for industrial use; proteins for use in manufacture; amino acids for industrial use; amino acids for scientific use; peptide substrates for scientific use; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; chemical preparations for use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; chemical reagents for use in genetic research; chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of anti-diabetes drugs; active chemical ingredients for use in the manufacture of drugs against metabolic diseases; active chemical ingredients for use in the manufacture of drugs for wound healing; active chemical ingredients for use in the manufacture of drugs against genetic diseases; active chemical ingredients for use in the manufacture of drugs against neurological diseases; amides for use in manufacture; chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research use; diagnostic preparationsother than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagentsother than for medical or veterinary use; biological preparations for use in industry and science; biological preparationsother than for medical or veterinary use; adjuvantsother than for medical or veterinary purposes; biochemical catalysts; biochemical preparations for scientific use; biochemicals for in vitro and in vivo scientific use; emollients for industrial use; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceuticals; enzyme stabilizers; enzyme substrates; phosphoproteins
Class 5
Chemical reagents for medical or veterinary use; reagents for medical use; peptides for medical use; protein arrays for medical diagnostic use; oligonucleotides for medical use; amino acids for medical use; peptides for pharmaceutical use; synthetic peptides for pharmaceutical use; peptides for veterinary use; amino acids for veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological and pharmaceutical preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary use; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; diagnostic kits containing diagnostic agentspreparations and substances for medical use; chemical preparations for the diagnosis of pregnancy; biological and chemical reagents for medical or veterinary use; biological preparations for diagnostic purposes; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations for wound healing; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against neurological diseases; biological reagents for medical use; biological reagents for veterinary use; adjuvants for medical use; adjuvants for veterinary use; anti-bacterial preparations for medical purposes; anti-cancer preparations; antitumor drugs; biopharmaceutical anti-tumor medicines; biopharmaceuticals for the treatment of cancer; anti-diabetic preparations; chemotherapeutics; cosmeceuticals for therapeutic or medical usemedicated soap; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic preparations adapted for medical use; dietetic preparations adapted for veterinary use; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing
Class 40
Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacturing of peptides; custom manufacturing of proteins; custom manufacturing of oligonucleotides; processing of chemicals; processing of chemical reagents; processing of peptides; processing of proteins; processing of oligonucleotides; processing of medicinal materials; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials
Class 42
Scientific research; chemical research; chemical engineering; product research and development; research and development of new products for others; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of methods of manufacture for peptidesproteinsoligonucleotidespharmaceuticalscosmetics; development of analytic methods for developing for peptidesproteinsoligonucleotidespharmaceuticalscosmetics; scientific laboratory services; chemical analysis; chemicalbiochemicalbiological and bacteriological research and analysis; analysis in the form of research in the field of molecular biology; conducting of scientific feasibility studies; providing information in the form of preparation of reports relating to scientific research; quality control; product testing; advisory services relating to material testing; consultancy in the field of biochemistry research; consultancy in the field of chemistry research; consultancy in the field of scientific and industrial research; consultancy relating to laboratory testing research; consulting services in the field of recombinant DNA technology research
Publications
History of USPTO decisions and trademark events.
43 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/19/2022
FIMP
FINAL DISPOSITION PROCESSED
09/19/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/07/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/29/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/13/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/26/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/01/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/01/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/07/2021
GNRT
NON-FINAL ACTION E-MAILED
07/07/2021
CNRT
NON-FINAL ACTION WRITTEN
07/07/2021
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
05/25/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/24/2021
GNFR
FINAL REFUSAL E-MAILED
02/24/2021
CNFR
FINAL REFUSAL WRITTEN
02/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2021
ALIE
ASSIGNED TO LIE
01/28/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2020
RFNT
REFUSAL PROCESSED BY IB
05/09/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/18/2020
RFRR
REFUSAL PROCESSED BY MPU
04/18/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/03/2020
CNRT
NON-FINAL ACTION WRITTEN
04/02/2020
DOCK
ASSIGNED TO EXAMINER
03/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/26/2020
Continuous trademark protection
Get notified about every new filing that threatens BACHEM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.